SCHEMBL13567940

SCHEMBL13567940

CC(C)[C@@H]1CC[C@@H](C)CC1OC(=O)N1C(=S)N[C@](C)(c2ccc(Cl)cc2)[C@@H]1c1ccc(C(F)(F)F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 5/20 0.37
MAPK1 P28482 3/20 0.37
MITF O75030 2/20 0.37
HTT P42858 2/20 0.37
KMT2A Q03164 2/20 0.37
TRPV1 Q8NER1 2/20 0.36
CYP19A1 P11511 2/20 0.36
MAPT P10636 2/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 1/20 0.35
MDM2 Q00987 2/20 0.33
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33
APH1B Q8WW43 1/20 0.33
NCSTN Q92542 1/20 0.33
APH1A Q96BI3 1/20 0.33
PSENEN Q9NZ42 1/20 0.33
EPHX1 P07099 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13567939 1.00 NPSR1 (0.37) NPSR1MAPK1MITFHTTKMT2A
SCHEMBL13568026 0.90 NPSR1 (0.38) NPSR1MAPK1MITFHTTKMT2A
SCHEMBL13567930 0.90 NPSR1 (0.38) NPSR1MAPK1MITFHTTKMT2A
SCHEMBL13568025 0.90 NPSR1 (0.38) NPSR1MAPK1MITFHTTKMT2A
SCHEMBL13567929 0.90 NPSR1 (0.38) NPSR1MAPK1MITFHTTKMT2A
SCHEMBL13567904 0.87 NPSR1 (0.37) NPSR1MAPK1MITFHTTKMT2A
SCHEMBL13567969 0.87 NPSR1 (0.37) NPSR1MAPK1MITFHTTKMT2A
SCHEMBL13567906 0.87 NPSR1 (0.37) NPSR1MAPK1MITFHTTKMT2A
SCHEMBL13567956 0.86 NPSR1 (0.41) NPSR1MAPK1MITFHTTKMT2A
SCHEMBL13567954 0.86 NPSR1 (0.41) NPSR1MAPK1MITFHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090312310-A1 Imidazothiazole derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312310-A1 Imidazothiazole derivatives TP53, MDM2, TP53BP1 NPSR1 4055/4885MAPK1 1186/4885MITF 806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.